Anavex Life Sciences Corp. (AVXL)

Anavex Life Sciences Statistics

Total Valuation

AVXL has a market cap or net worth of $300.63 million. The enterprise value is $203.76 million.

Market Cap	300.63M
Enterprise Value	203.76M

Important Dates

The next estimated earnings date is Monday, December 22, 2025, before market open.

Earnings Date	Dec 22, 2025
Ex-Dividend Date	n/a

Share Statistics

AVXL has 85.89 million shares outstanding. The number of shares has increased by 2.72% in one year.

Current Share Class	85.89M
Shares Outstanding	85.89M
Shares Change (YoY)	+2.72%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	3.36%
Owned by Institutions (%)	38.14%
Float	83.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.36
P/TBV Ratio	3.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.93

Current Ratio	8.93
Quick Ratio	8.89
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.64% and return on invested capital (ROIC) is -30.30%.

Return on Equity (ROE)	-43.64%
Return on Assets (ROA)	-27.41%
Return on Invested Capital (ROIC)	-30.30%
Return on Capital Employed (ROCE)	-58.82%
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.99% in the last 52 weeks. The beta is 1.10, so AVXL's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	-52.99%
50-Day Moving Average	8.25
200-Day Moving Average	9.01
Relative Strength Index (RSI)	13.78
Average Volume (20 Days)	3,261,983

Short Selling Information

The latest short interest is 26.66 million, so 31.04% of the outstanding shares have been sold short.

Short Interest	26.66M
Short Previous Month	26.62M
Short % of Shares Out	31.04%
Short % of Float	32.12%
Short Ratio (days to cover)	19.82

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-53.50M
Pretax Income	-48.17M
Net Income	-48.17M
EBITDA	n/a
EBIT	-53.50M
Earnings Per Share (EPS)	-$0.57

Balance Sheet

The company has $101.16 million in cash and n/a in debt, giving a net cash position of $101.16 million or $1.18 per share.

Cash & Cash Equivalents	101.16M
Total Debt	n/a
Net Cash	101.16M
Net Cash Per Share	$1.18
Equity (Book Value)	90.96M
Book Value Per Share	1.06
Working Capital	90.96M

Cash Flow

Operating Cash Flow	-37.10M
Capital Expenditures	n/a
Free Cash Flow	-37.10M
FCF Per Share	-$0.43

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVXL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.72%
Shareholder Yield	-2.72%
Earnings Yield	-15.80%
FCF Yield	-12.17%

Analyst Forecast

The average price target for AVXL is $33.00, which is 842.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.00
Price Target Difference	842.86%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 7, 2015. It was a reverse split with a ratio of 1:4.

Last Split Date	Oct 7, 2015
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1